The Use of Milnacipran in Treating Fibromyalgia

1. The Use of Milnacipran in
Treating Fibromyalgia

2. Milnacipran, also known as milnacipran
hydrochloride or Savella, helps to alleviate the
pain caused by fibromyalgia through blocking the
reuptake of serotonin and norepinephrine. During
two double-blind clinical trials, Milcanipran has
been shown to decrease pain experienced by
patients with fibromyalgia by as much as 30
percent. Furthermore, patients reporting the most
improvement benefitted from the drug in as little
as one week after initiating treatment.

3. Currently marketed by Forest Laboratories,
Milnacipran was developed by Cypress
Biosciences, Inc., with support from physician and
pharmaceutical investor Lindsay Rosenwald, MD,
who co-founded Opus Point Partners, Cougar
Biotechnologies, Inc., and numerous other
companies. Aided by his decades of experience in
the pharmaceutical industry, Dr. Lindsay
Rosenwald played a major role in gaining FDA
approval for Milnacipran in 2009, and has secured
approval for the marketing of drugs for the
treatment of leukemia, prostate cancer, obesity,
and rheumatoid arthritis as well.

4. For more information on Milnacipran and Cypress
Bioscience, visit www.cypressbio.com.